BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16439939)

  • 21. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of ischemic stroke: antithrombotic therapy in cardiac embolism.
    Cervera A; Amaro S; Obach V; Chamorro A
    Curr Drug Targets; 2007 Jul; 8(7):824-31. PubMed ID: 17630935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cerebral infarction].
    Uchiyama S
    Nihon Rinsho; 2006 Nov; 64(11):2039-44. PubMed ID: 17087294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic treatment in the prevention of ischemic stroke.
    Emre U; Rantanen K; Tatlisumak T
    Curr Drug Targets; 2007 Jul; 8(7):817-23. PubMed ID: 17630934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2004 Sep; 126(3 Suppl):483S-512S. PubMed ID: 15383482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
    Dzeshka MS; Lip GY
    Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies.
    Touzé E; Cambou JP; Ferrières J; Vahanian A; Coppé G; Leizorovicz A; Jullien G; Guérillot M; Herrmann MA; Mas JL
    Cerebrovasc Dis; 2005; 20(2):78-84. PubMed ID: 15976499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic Therapy After TAVR.
    Geisler T; Droppa M; Muller K; Borst O
    Curr Vasc Pharmacol; 2018; 16(5):437-445. PubMed ID: 29345593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.